Calliditas Therapeutics: Calliditas' partner Everest Medicin

Calliditas Therapeutics: Calliditas' partner Everest Medicines announces China NMPA's approval of Nefecon® for the treatment of primary IgA nephropathy

Calliditas Therapeutics: Calliditas' partner Everest Medicines announces China NMPA's approval of Nefecon® for the treatment of primary IgA nephropathy

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

China , Hong Kong , Singapore , Macau , Stockholm , Sweden , United States , American , Chinese , Stefan Klotter , American Society Of Nephrology , China National Medical Products Administration , Nasdaq Stockholm , Everest Medicines , National Medical Products Administration , New Drug Application , American Society , Kidney Week , Lassen Sie ,